Cargando…
Biochemical and Structural Characterization of Mycobacterial Aspartyl-tRNA Synthetase AspS, a Promising TB Drug Target
The human pathogen Mycobacterium tuberculosis is the causative agent of pulmonary tuberculosis (TB), a disease with high worldwide mortality rates. Current treatment programs are under significant threat from multi-drug and extensively-drug resistant strains of M. tuberculosis, and it is essential t...
Autores principales: | Gurcha, Sudagar S., Usha, Veeraraghavan, Cox, Jonathan A. G., Fütterer, Klaus, Abrahams, Katherine A., Bhatt, Apoorva, Alderwick, Luke J., Reynolds, Robert C., Loman, Nicholas J., Nataraj, VijayaShankar, Alemparte, Carlos, Barros, David, Lloyd, Adrian J., Ballell, Lluis, Hobrath, Judith V., Besra, Gurdyal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237437/ https://www.ncbi.nlm.nih.gov/pubmed/25409504 http://dx.doi.org/10.1371/journal.pone.0113568 |
Ejemplares similares
-
Identification of Novel Mt-Guab2 Inhibitor Series Active against M. tuberculosis
por: Usha, Veeraraghavan, et al.
Publicado: (2012) -
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface
por: Abrahams, Katherine A., et al.
Publicado: (2017) -
Development of a whole‐cell high‐throughput phenotypic screen to identify inhibitors of mycobacterial amino acid biosynthesis
por: Burke, Christopher, et al.
Publicado: (2019) -
Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach
por: Soto, Ramón, et al.
Publicado: (2018) -
DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)